Skip to content

A single-center randomized controlled clinical study on the efficacy of Chinese medicine for removing dampness in treating influenza dampness syndrome

A single-center randomized controlled clinical study on the efficacy of Chinese medicine for removing dampness in treating influenza dampness syndrome

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000335
Enrollment
Unknown
Registered
2024-08-31
Start date
2024-04-23
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

treatment group :Compound Elsholtzia Liquid
treatment group:Qingjie granule +Oseltamivir
treatment group: Huoxiang Zhengqi oral liquid+Oseltamivir
treatment group: Compound Elsholtzia Liquid+Oseltamivir

Sponsors

Guangzhou Eighth People's Hospital, Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1)Age 18-60 years old; (2)Conform to the diagnostic criteria of influenza; (3)Axillary temperature = 38 °C; (4)onset time within 72 hours

Exclusion criteria

Exclusion criteria: (1)Pregnant and lactating women (2)Patients with the following diseases or conditions : pneumonia, suppurative tonsillitis, acute tracheobronchitis, acute pharyngitis, acute exacerbation of nasal diseases ( such as allergic rhinitis, chronic rhinitis, acute and chronic sinusitis, etc. ), chronic respiratory diseases ( such as chronic obstructive pulmonary disease, interstitial lung disease, etc. ), asthma, tuberculosis ; severe primary diseases such as heart, brain, lung, liver, kidney and blood system, such as unstable control / severe complications of diabetes, viral hepatitis, hemophilia ; mental illness ; immunosuppressive status ( including immunosuppressive agents or HIV infection ) ; (3)Allergic to alcohol and test drug ingredients (4)Those who had been vaccinated against influenza within 1 year (5)After the onset of the disease,who took anti-influenza virus drugs,or traditional chinese medicine with the same function of the test drug.

Design outcomes

Primary

MeasureTime frame
Clinical recovery time;

Secondary

MeasureTime frame
Improvement of single syndrome of traditional Chinese medicine;Complications and severe rate;virus negative conversion ratio;Antipyretic onset time;complete cooling time;

Countries

China

Contacts

Public ContactXiemin

Guangzhou Eighth People's Hospital, Guangzhou Medical University

gz8hxiemin@126.com020-36052110

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026